ASTERDM - Fundamental Analysis: Financial Health & Valuation
← Back to ListKey Parameters
⭐ Fundamental Rating: 2.3
Show all parameters (20 more)
🏭 Industry
The healthcare sector, particularly quaternary care facilities like Aster DM operates within, often exhibits stable demand driven by an aging population and increasing chronic disease prevalence. However, margins are typically under pressure due to rising operational costs and competitive pricing pressures; therefore, consistent profitability is a key characteristic of this industry.
✅ Positive
The company demonstrates a relatively conservative capital structure with a debt-to-equity ratio of 0.43, suggesting financial stability and limited reliance on external financing. Furthermore, the dividend yield of 0.39% provides some return to shareholders, although it is typical for this industry.
⚠️ Limitation
PAT Qtr experienced a significant decline (-28.0%) compared to the previous quarter, raising concerns about earnings quality and potentially indicating temporary headwinds. The high P/E ratio of 215 relative to the industry average (49.6) suggests that the stock is trading at a premium valuation and may be vulnerable to price corrections if growth expectations aren’t met.
🧾 Long-Term Outlook
We recommend a cautious entry zone around 680-710 ₹, reflecting a slight discount to the current price given the earnings decline. Long-term holding guidance would be predicated on demonstrating a return to consistent PAT growth and maintaining disciplined capital management. The valuation remains elevated compared to its peers but warrants further investigation if operational challenges can be overcome. Overall, this is a cautious buy with moderate downside risk until clearer signals emerge regarding future profitability.